List of Chapters/Sections(Table Of Content)
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Immunotherapy Revenue
1.4 Market Analysis by Type
1.4.1 Global Immunotherapy Market Size Growth Rate by Type: 2021 VS 2027
1.4.2 Monoclonal Antibodies
1.4.3 Therapeutic Vaccines
1.4.4 Checkpoint Inhibitors
1.4.5 Non-Specific Immunotherapy
1.5 Market by Application
1.5.1 Global Immunotherapy Market Share by Application: 2022-2027
1.5.2 Oncology
1.5.3 Inflammation
1.5.4 Central Nervous System
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Immunotherapy Market
1.8.1 Global Immunotherapy Market Status and Outlook (2016-2027)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Immunotherapy Production Capacity Market Share by Manufacturers (2016-2021)
2.2 Global Immunotherapy Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Immunotherapy Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Immunotherapy Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Immunotherapy Sales Volume Market Share by Region (2016-2021)
3.2 Global Immunotherapy Sales Revenue Market Share by Region (2016-2021)
3.3 North America Immunotherapy Sales Volume
3.3.1 North America Immunotherapy Sales Volume Growth Rate (2016-2021)
3.3.2 North America Immunotherapy Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.4 East Asia Immunotherapy Sales Volume
3.4.1 East Asia Immunotherapy Sales Volume Growth Rate (2016-2021)
3.4.2 East Asia Immunotherapy Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.5 Europe Immunotherapy Sales Volume (2016-2021)
3.5.1 Europe Immunotherapy Sales Volume Growth Rate (2016-2021)
3.5.2 Europe Immunotherapy Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.6 South Asia Immunotherapy Sales Volume (2016-2021)
3.6.1 South Asia Immunotherapy Sales Volume Growth Rate (2016-2021)
3.6.2 South Asia Immunotherapy Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.7 Southeast Asia Immunotherapy Sales Volume (2016-2021)
3.7.1 Southeast Asia Immunotherapy Sales Volume Growth Rate (2016-2021)
3.7.2 Southeast Asia Immunotherapy Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.8 Middle East Immunotherapy Sales Volume (2016-2021)
3.8.1 Middle East Immunotherapy Sales Volume Growth Rate (2016-2021)
3.8.2 Middle East Immunotherapy Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.9 Africa Immunotherapy Sales Volume (2016-2021)
3.9.1 Africa Immunotherapy Sales Volume Growth Rate (2016-2021)
3.9.2 Africa Immunotherapy Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.10 Oceania Immunotherapy Sales Volume (2016-2021)
3.10.1 Oceania Immunotherapy Sales Volume Growth Rate (2016-2021)
3.10.2 Oceania Immunotherapy Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.11 South America Immunotherapy Sales Volume (2016-2021)
3.11.1 South America Immunotherapy Sales Volume Growth Rate (2016-2021)
3.11.2 South America Immunotherapy Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.12 Rest of the World Immunotherapy Sales Volume (2016-2021)
3.12.1 Rest of the World Immunotherapy Sales Volume Growth Rate (2016-2021)
3.12.2 Rest of the World Immunotherapy Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
4 North America
4.1 North America Immunotherapy Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Immunotherapy Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Immunotherapy Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Immunotherapy Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Immunotherapy Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Immunotherapy Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Immunotherapy Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Immunotherapy Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Immunotherapy Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Immunotherapy Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Immunotherapy Sales Volume Market Share by Type (2016-2021)
14.2 Global Immunotherapy Sales Revenue Market Share by Type (2016-2021)
14.3 Global Immunotherapy Sales Price by Type (2016-2021)
15 Consumption Analysis by Application
15.1 Global Immunotherapy Consumption Volume by Application (2016-2021)
15.2 Global Immunotherapy Consumption Value by Application (2016-2021)
16 Company Profiles and Key Figures in Immunotherapy Business
16.1 Abbvie
16.1.1 Abbvie Company Profile
16.1.2 Abbvie Immunotherapy Product Specification
16.1.3 Abbvie Immunotherapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.2 Amgen, Inc.
16.2.1 Amgen, Inc. Company Profile
16.2.2 Amgen, Inc. Immunotherapy Product Specification
16.2.3 Amgen, Inc. Immunotherapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.3 Biogen
16.3.1 Biogen Company Profile
16.3.2 Biogen Immunotherapy Product Specification
16.3.3 Biogen Immunotherapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.4 Bristol-Myers Squibb
16.4.1 Bristol-Myers Squibb Company Profile
16.4.2 Bristol-Myers Squibb Immunotherapy Product Specification
16.4.3 Bristol-Myers Squibb Immunotherapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.5 Celgene
16.5.1 Celgene Company Profile
16.5.2 Celgene Immunotherapy Product Specification
16.5.3 Celgene Immunotherapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.6 Johnson & Johnson
16.6.1 Johnson & Johnson Company Profile
16.6.2 Johnson & Johnson Immunotherapy Product Specification
16.6.3 Johnson & Johnson Immunotherapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.7 Merck
16.7.1 Merck Company Profile
16.7.2 Merck Immunotherapy Product Specification
16.7.3 Merck Immunotherapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.8 Novartis
16.8.1 Novartis Company Profile
16.8.2 Novartis Immunotherapy Product Specification
16.8.3 Novartis Immunotherapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.9 Pfizer
16.9.1 Pfizer Company Profile
16.9.2 Pfizer Immunotherapy Product Specification
16.9.3 Pfizer Immunotherapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.10 Roche
16.10.1 Roche Company Profile
16.10.2 Roche Immunotherapy Product Specification
16.10.3 Roche Immunotherapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)
17 Immunotherapy Manufacturing Cost Analysis
17.1 Immunotherapy Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Immunotherapy
17.4 Immunotherapy Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Immunotherapy Distributors List
18.3 Immunotherapy Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Immunotherapy (2022-2027)
20.2 Global Forecasted Revenue of Immunotherapy (2022-2027)
20.3 Global Forecasted Price of Immunotherapy (2016-2027)
20.4 Global Forecasted Production of Immunotherapy by Region (2022-2027)
20.4.1 North America Immunotherapy Production, Revenue Forecast (2022-2027)
20.4.2 East Asia Immunotherapy Production, Revenue Forecast (2022-2027)
20.4.3 Europe Immunotherapy Production, Revenue Forecast (2022-2027)
20.4.4 South Asia Immunotherapy Production, Revenue Forecast (2022-2027)
20.4.5 Southeast Asia Immunotherapy Production, Revenue Forecast (2022-2027)
20.4.6 Middle East Immunotherapy Production, Revenue Forecast (2022-2027)
20.4.7 Africa Immunotherapy Production, Revenue Forecast (2022-2027)
20.4.8 Oceania Immunotherapy Production, Revenue Forecast (2022-2027)
20.4.9 South America Immunotherapy Production, Revenue Forecast (2022-2027)
20.4.10 Rest of the World Immunotherapy Production, Revenue Forecast (2022-2027)
20.5 Forecast by Type and by Application (2022-2027)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027)
20.5.2 Global Forecasted Consumption of Immunotherapy by Application (2022-2027)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Immunotherapy by Country
21.2 East Asia Market Forecasted Consumption of Immunotherapy by Country
21.3 Europe Market Forecasted Consumption of Immunotherapy by Countriy
21.4 South Asia Forecasted Consumption of Immunotherapy by Country
21.5 Southeast Asia Forecasted Consumption of Immunotherapy by Country
21.6 Middle East Forecasted Consumption of Immunotherapy by Country
21.7 Africa Forecasted Consumption of Immunotherapy by Country
21.8 Oceania Forecasted Consumption of Immunotherapy by Country
21.9 South America Forecasted Consumption of Immunotherapy by Country
21.10 Rest of the world Forecasted Consumption of Immunotherapy by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer
